Herbalife Nutrition (NYSE:HLF) Rating Lowered to Sell at Zacks Investment Research

Herbalife Nutrition (NYSE:HLF) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Wednesday, Zacks.com reports.

According to Zacks, “Herbalife is a global network marketing company offering a range of science-based weight management products, nutritional supplements and personal care products intended to support weight loss and a healthy lifestyle. “

Several other research firms also recently weighed in on HLF. Pi Financial upgraded shares of Herbalife Nutrition from a “neutral” rating to a “buy” rating and increased their price target for the stock from $8.75 to $12.75 in a research report on Thursday, August 8th. ValuEngine raised shares of Herbalife Nutrition from a “sell” rating to a “hold” rating in a research note on Thursday, August 1st. Citigroup reduced their price objective on shares of Herbalife Nutrition from $66.00 to $57.00 and set a “buy” rating for the company in a research note on Friday, August 2nd. Pivotal Research reissued a “buy” rating and issued a $65.00 price objective (down from $75.00) on shares of Herbalife Nutrition in a research note on Friday, August 2nd. Finally, Royal Bank of Canada reissued a “hold” rating and issued a $10.00 price objective on shares of Herbalife Nutrition in a research note on Thursday, August 8th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and five have issued a buy rating to the stock. Herbalife Nutrition presently has an average rating of “Hold” and a consensus price target of $49.25.

HLF opened at $35.69 on Wednesday. Herbalife Nutrition has a 1-year low of $34.73 and a 1-year high of $61.77. The company has a market capitalization of $5.31 billion, a PE ratio of 12.39 and a beta of 0.43. The firm’s 50 day simple moving average is $39.58 and its two-hundred day simple moving average is $47.95.

Herbalife Nutrition (NYSE:HLF) last released its quarterly earnings results on Thursday, August 1st. The company reported $0.70 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.75 by ($0.05). Herbalife Nutrition had a negative return on equity of 58.68% and a net margin of 6.05%. The business had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.30 billion. During the same quarter in the previous year, the business posted $0.80 earnings per share. The firm’s revenue was down 3.5% on a year-over-year basis. As a group, research analysts expect that Herbalife Nutrition will post 2.61 earnings per share for the current year.

Several hedge funds and other institutional investors have recently made changes to their positions in HLF. Quadrant Capital Group LLC increased its stake in shares of Herbalife Nutrition by 452.0% in the first quarter. Quadrant Capital Group LLC now owns 541 shares of the company’s stock worth $28,000 after purchasing an additional 443 shares in the last quarter. Doyle Wealth Management purchased a new stake in shares of Herbalife Nutrition in the second quarter worth $37,000. SG Americas Securities LLC increased its stake in shares of Herbalife Nutrition by 16.7% in the second quarter. SG Americas Securities LLC now owns 3,010 shares of the company’s stock worth $129,000 after purchasing an additional 430 shares in the last quarter. Phocas Financial Corp. purchased a new stake in shares of Herbalife Nutrition in the second quarter worth $133,000. Finally, World Asset Management Inc purchased a new stake in shares of Herbalife Nutrition in the first quarter worth $204,000. 93.72% of the stock is owned by hedge funds and other institutional investors.

About Herbalife Nutrition

Herbalife Nutrition Ltd. develops and sells nutrition solutions in North America, Mexico, South and Central America, Europe, the Middle East, Africa, and the Asia Pacific. It provides science-based products in the areas of weight management; targeted nutrition; energy, sports, and fitness; and outer nutrition.

Further Reading: What is an overbought condition?

Get a free copy of the Zacks research report on Herbalife Nutrition (HLF)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Herbalife Nutrition (NYSE:HLF)

Receive News & Ratings for Herbalife Nutrition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Herbalife Nutrition and related companies with MarketBeat.com's FREE daily email newsletter.